Division of Pulmonology and Allergy, Department of Internal Medicine, College of Medicine, Yeungnam University and Regional Center for Respiratory Diseases, Yeungnam University Medical Center, Daegu, Korea.
Division of Infection, Department of Internal Medicine, College of Medicine, Yeungnam University, Yeungnam University Medical Center, Daegu, Korea.
J Korean Med Sci. 2020 Jun 29;35(25):e234. doi: 10.3346/jkms.2020.35.e234.
The case fatality rate of coronavirus disease 2019 (COVID-19) is estimated to be between 4.3% and 11.0%. Currently there is no effective antiviral treatment for COVID-19. Thus, early recognition of patients at high risk is important.
We performed a retrospective observational study of 110 patients with severe acute respiratory syndrome coronavirus 2 infection. We compared the effectiveness of three scoring systems: the Systemic Inflammatory Response Syndrome (SIRS), quick Sequential Organ Failure Assessment (qSOFA), and National Early Warning Score (NEWS) systems, for predicting the prognosis of COVID-19. The area under the receiver operating characteristic curve (AUROC) was used for these assessments, and Kaplan-Meier survival curves were used to identify the cumulative risk for 28-day mortality according to the NEWS stratification.
For predicting 28-day mortality, NEWS was superior to qSOFA (AUROC, 0.867 vs. 0.779, P < 0.001), while there was no significant difference between NEWS and SIRS (AUROC, 0.867 vs. 0.639, = 0.100). For predicting critical outcomes, NEWS was superior to both SIRS (AUROC, 0.918 vs. 0.744, = 0.032) and qSOFA (AUROC, 0.918 vs. 0.760, = 0.012). Survival time was significantly shorter for patients with NEWS ≥ 7 than for patients with NEWS < 7.
Calculation of the NEWS at the time of hospital admission can predict critical outcomes in patients with COVID-19. Early intervention for high-risk patients can thereby improve clinical outcomes in COVID-19 patients.
2019 年冠状病毒病(COVID-19)的病死率估计在 4.3%至 11.0%之间。目前尚无针对 COVID-19 的有效抗病毒治疗方法。因此,早期识别高危患者很重要。
我们对 110 例严重急性呼吸综合征冠状病毒 2 感染患者进行了回顾性观察研究。我们比较了三种评分系统的效果:全身炎症反应综合征(SIRS)、快速序贯器官衰竭评估(qSOFA)和英国国家早期预警评分(NEWS)系统,以预测 COVID-19 的预后。使用受试者工作特征曲线下面积(AUROC)进行这些评估,并使用 Kaplan-Meier 生存曲线根据 NEWS 分层确定 28 天死亡率的累积风险。
对于预测 28 天死亡率,NEWS 优于 qSOFA(AUROC,0.867 比 0.779,P < 0.001),而 NEWS 与 SIRS 之间无显著差异(AUROC,0.867 比 0.639,P = 0.100)。对于预测危急预后,NEWS 优于 SIRS(AUROC,0.918 比 0.744,P = 0.032)和 qSOFA(AUROC,0.918 比 0.760,P = 0.012)。NEWS ≥ 7 的患者的生存时间明显短于 NEWS < 7 的患者。
入院时计算 NEWS 可预测 COVID-19 患者的危急预后。对高危患者进行早期干预可以改善 COVID-19 患者的临床结局。